Next Significant Milestone, page-17

He's got to be frustrated. He pulled a rabbit from the hat with BioHorizons deal on Striate and investors have not given him the accolades I am sure he felt due via the share price and improved wealth himself. It seems investors need to see actual deal figures on this one (hopefully clearer in Appendix 4C at month end).

J&J, Stryker, Smith & Nephwew etc, cannot be oblivious to the Striate deal with BH and looking at CelGro tendon/rope and ATI orthopedic applications in their own businesses. Zimmer Biomet definitely not unaware:

https://www.massdevice.com/10-largest-orthopedic-device-companies-in-the-world-2022/

I wouldn't be surprised if Mr Anderson is frustrated that investors can't hear the inevitability ("You Hear That [said] Mr. Anderson? That Is The Sound Of Inevitability!").

I am fairly confident he will have some dialogue going on with the big boys and will be as frustrated at the share price with BH deal as we are and dying to tell all.